Buy silly dots mushroom Online Now From US
Order silly dots mushroom, Prepare for an elevated adventure—each tablet packs a mega-dose of potent mushroom extracts and nootropics to enhance cognition, perception, and sensory experiences. Delivered in a precise, scored tablet format for clean, reliable dosing.
Key Features & Benefits: silly dots mushroom
-
1200 mg active blend per tablet, featuring a proprietary mix of adaptogenic mushrooms and cognitive-enhancing nootropics
-
Six servings per pack—each tablet scores into two 600 mg doses for flexibility
-
Clean formulation: natural binders and fillers, sustainably sourced mushroom extract
-
Third-party lab tested for potency, safety, and absence of contaminants
How to Dose
-
½ tablet (600 mg) – Flow & Vibin’: gentle boost for creativity and mood
-
1 tablet (1200 mg) – Euphoria & Introspection: deeper mental exploration and bliss
-
1½ tablets or 3 tabs – Altered Perception: vivid sensory expansion and perceptual shifts
Onset typically occurs within 30–60 minutes; effects may last several hours
Recommended Use & Safety
-
Start low, go slow—begin with half a tablet to assess sensitivity
-
Follow a 5‑days-on / 2‑days-off routine
-
Maximum: No more than 3 tablets within 12 hours
-
Not for individuals under 21, pregnant/nursing, or those on SSRIs (may blunt effects)
Why Choose Silly Dots Mega Dose?
-
Ultra‑potent: tailored for seasoned psychonauts seeking deep introspection or sensory expansion
-
Precise dosing: scored tablets allow micro- to mega-dose flexibility
-
Premium quality: sustainable ingredients, lab-tested for safety
-
Portable & discreet: easy to carry for controlled, on-the-go use
Final Thoughts
Silly Dots Mega Dose 1200 mg Tabs offer a powerful and customizable experience that can range from creative flow to profound perceptual voyages. With responsibly designed dosing and rigorous testing, it’s a top-tier choice for users ready for intensity. But start conservatively—effects are strong, and individual response can vary dramatically.
Reviews
There are no reviews yet.